Business Description
EXoZymes Inc
NAICS : 541715
SIC : 2834
ISIN : US4618741098
Total Employee Number:
32Description
EXoZymes Inc is focused on using a biomanufacturing platform to create valuable biochemicals, including Active Pharmaceutical Ingredients or APIs, biofuels, food flavors, and cosmetics, offering a sustainable alternative to traditional chemical production methods. The company believes its platform will enable scalable production of chemical molecules found in nature in a process that is alternative to and more environmentally friendly and sustainable than the typical methods used today, such as chemical synthesis, natural extraction, and synthetic biology.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.24 | |||||
Equity-to-Asset | 0.38 | |||||
Debt-to-Equity | 0.76 | |||||
Debt-to-EBITDA | -0.12 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -97.5 | |||||
3-Year EPS without NRI Growth Rate | -85.1 | |||||
3-Year FCF Growth Rate | -64.8 | |||||
3-Year Book Growth Rate | 33.7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 65.73 | |||||
9-Day RSI | 55.82 | |||||
14-Day RSI | 51.03 | |||||
3-1 Month Momentum % | 31.09 | |||||
6-1 Month Momentum % | -9.68 | |||||
12-1 Month Momentum % | -0.35 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.32 | |||||
Quick Ratio | 1.32 | |||||
Cash Ratio | 0.91 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.1 | |||||
Shareholder Yield % | 2.27 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -183.06 | |||||
ROA % | -124.28 | |||||
ROIC % | -424.58 | |||||
3-Year ROIIC % | -1149.06 | |||||
ROC (Joel Greenblatt) % | -507.04 | |||||
ROCE % | -159.3 | |||||
Moat Score | 5 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 46.83 | |||||
Price-to-Tangible-Book | 46.83 | |||||
EV-to-EBIT | -7.54 | |||||
EV-to-EBITDA | -7.76 | |||||
EV-to-FCF | -10.79 | |||||
Earnings Yield (Greenblatt) % | -13.26 | |||||
FCF Yield % | -9.23 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:EXOZ
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
EXoZymes Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -1.14 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 75.59 | ||
| 14-Day RSI | 51.03 | ||
| 14-Day ATR ($) | 0.837656 | ||
| 20-Day SMA ($) | 8.032 | ||
| 12-1 Month Momentum % | -0.35 | ||
| 52-Week Range ($) | 6.33 - 18.4 | ||
| Shares Outstanding (Mil) | 9.11 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
EXoZymes Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
EXoZymes Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-13 17:00 | In 136 days | ||
| Third quarter earnings results for 2026 | 2026-11-13 | In 135 days | ||
| Second quarter earnings results for 2026 | 2026-08-12 | In 42 days | ||
| General meeting for 2026 | 2026-07-24 13:00 | In 24 days | ||
| Guidance call for 2024 | 2026-06-24 10:00 | 7.70 (-3.99%) | ||
| First quarter earnings results for 2026 | 2026-05-14 | 9.88 (+0.00%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-03-31 17:30 | 7.30 (-0.14%) | ||
| Fourth quarter earnings results for 2025 | 2026-03-31 | 7.30 (-0.14%) | ||
| Annual report for 2025 | 2026-03-30 | 7.15 (-4.03%) | ||
| Third quarter earnings conference call for 2025 | 2025-11-13 17:00 | 16.50 (+3.13%) |
Show
Entries
EXoZymes Inc Frequently Asked Questions
What is EXoZymes Inc(EXOZ)'s stock price today?
The current price of EXOZ is $8.43. The 52 week high of EXOZ is $18.40 and 52 week low is $6.33.
When is next earnings date of EXoZymes Inc(EXOZ)?
The next earnings date of EXoZymes Inc(EXOZ) is 2026-08-12 Est..
Does EXoZymes Inc(EXOZ) pay dividends? If so, how much?
EXoZymes Inc(EXOZ) does not pay dividend.
Guru Commentaries on NAS:EXOZ
No articles.
Press Release
Articles on EXoZymes Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers